Author

Trish Hammerschmidt

Institution: Washington University in St. Louis

Observed institution: Washington University in St. Louis

OpenAlex ID: A5044749929

A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)

2023 · Foluso O. Ademuyiwa, Donald W. Northfelt, et al. · npj Breast Cancer · 22

Abstract P2-13-01: Phase 2 study of neoadjuvant palbociclib, letrozole, and trastuzumab in patients with ER+ HER2+ breast cancer (PALTAN)

2022 · Foluso O Ademuyiwa, Donald Northfelt, et al. · Cancer Research · 3

Abstract P3-06-07: Phase Ib/II study to evaluate safety and tolerability of cabiralizumab in combination with nivolumab and neoadjuvant chemotherapy in patients with localized triple-negative breast cancer

2023 · Andrew A. Davis, Leonel Hernandez-Aya, et al. · Cancer Research · 2

Works count: 3

Citation count: 27

H-index: 2

I10-index: 1